NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHGRI E-236-1999-0-RU-08 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC RU National Stage 2000133327 Expired
NHGRI E-236-1999-0-AU-04 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC AU National Stage 41013/99 Abandoned
NHLBI E-127-1998-0-AU-03 AAV5 AND USES THEREOF AU National Stage 42205/99 Expired
NHGRI E-236-1999-0-ZA-19 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC ZA National Stage 2000/07321 Expired
NIDDK E-177-1992-1-US-01 EXPRESSION OF A HETEROLOGOUS PROTEIN C IN MAMMARY TISSUE OF TRANSGENIC ANIMALS USING A LONG WHEY ACID PROTEIN PROMOTER US CIP 09/321,831 6262336 Expired PDF
NHGRI E-236-1999-0-SG-17 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC SG National Stage 200006997-1 Expired
NIMH E-162-1998-0-PCT-02 MAMMALIAN GB2 GABAB RECEPTORS PCT PCT PCT/US1999/011869 Expired
NHLBI E-127-1998-0-PCT-02 AAV5 VECTOR AND USES THEREOF PCT PCT PCT/US1999/011958 Expired
NHGRI E-236-1999-0-PCT-02 Methods and Compositions Useful for Modulation of Angiogensis Using Tyrosine Kinase SRC PCT PCT PCT/US1999/011780 Expired
NHGRI E-236-1999-0-KR-16 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC KR National Stage 10-2000-7013490 Abandoned
NHGRI E-236-1999-0-BR-05 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC BR National Stage PI9910787-2 Abandoned
NHGRI E-236-1999-0-HU-11 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC HU National Stage P0102614 Expired
NIMH E-089-1998-0-US-01 Two Enterocin-Producing strains Of Bacteria And their Enterocins,Both Of Which Are Lethal To Vancomycin-Resistant Enterococcus Faecium...... US 60/136,789 Abandoned
NIDA E-196-1999-0-US-01 cDNA Fragment T155c, From SV 40 Gene SV40 Large T, for Immortalizing Cells US 60/136,492 Abandoned
NCI E-181-1999-0-US-01 Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Virus Vector US 60/137,126 Abandoned
CC E-090-1999-0-US-01 Dual HDL/Total Cholesterol Test US 60/136,709 Abandoned
NCI E-250-2000-0-US-01 Immortalized Human Ear Epithelial Cell Line. US 60/136,736 Abandoned
NCI E-139-1999-0-US-01 IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY Affinity Improvement of scFVsr ab's w/higher affinity for Mesothelin US 60/160,071 Abandoned
NCI E-054-1994-0-US-03 METHOD OF INDUCING CELL-MEDIATED PROTECTIVE IMMUNITY AGAINST HIV USING LOW DOSES OF IMMUNOGENS US CON 09/321,498 Abandoned
CC E-142-1998-0-PCT-02 METHODS FOR LABELING NUCLEIC ACID VECTORS WITH TRIPLEX-FORMING OLIGONUCLEOTIDES AND MONITORING VECTOR DISTRIBUTION IN VIVO PCT PCT PCT/US1999/011511 Expired
NIDDK E-193-1999-0-US-01 1,3-Dialkylzanthine Derivative for Treatment For Asthma US 60/136,041 Abandoned
NCI E-194-1994-1-US-03 SUBSTITUTED O6-BENZYL-8-AZA-GUANINES AND 6(4) - BENZYLOXPYRIMIDINES US DIV 09/318,238 6172070 Abandoned PDF
NICHD E-016-1996-0-US-24 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS US National Stage 09/180,132 6861415 Expired PDF
NHLBI E-196-1998-2-EP-03 Methods for Pressure Mediated Selective Delivery of Therapeutic Substances and Cannula EP National Stage 99924424.7 Abandoned
NHLBI E-196-1998-2-IT-14 Methods for Pressure Mediated Selective Delivery of Therapeutic Substances and Cannula IT EP 99924424.7 Abandoned
NHLBI E-196-1998-2-AT-08 Methods for Pressure Mediated Selective Delivery of Therapeutic Substances and Cannula AT EP 99924424.7 Abandoned
NHLBI E-196-1998-2-NL-13 Methods for Pressure Mediated Selective Delivery of Therapeutic Substances and Cannula NL EP 99924424.7 Abandoned
NHLBI E-196-1998-2-GB-12 Methods for Pressure Mediated Selective Delivery of Therapeutic Substances and Cannula GB EP 99924424.7 Abandoned
NHLBI E-196-1998-2-CH-11 Methods for Pressure Mediated Selective Delivery of Therapeutic Substances and Cannula CH EP 99924424.7 Abandoned
NHLBI E-196-1998-2-FR-09 Methods for Pressure Mediated Selective Delivery of Therapeutic Substances and Cannula FR EP 99924424.7 Abandoned
NHLBI E-196-1998-2-DE-10 Methods for Pressure Mediated Selective Delivery of Therapeutic Substances and Cannula DE EP 99924424.7 Abandoned
NHLBI E-196-1998-2-AU-04 Pressure Mediated Selective Delivery of Therapeutic Substances AU National Stage 40930/99 Abandoned
NHLBI E-196-1998-2-PCT-01 METHOD FOR PRESSURE MEDIATED SELECTIVE DELIVERY OF THERAPEUTIC SUBSTANCES AND CANNULA PCT PCT COMB PCT/US1999/011277 Expired
NHLBI E-196-1998-2-JP-06 Pressure Mediated Selective Delivery of Therapeutic Substances JP National Stage 2000-549328 Abandoned
NHLBI E-196-1998-2-KR-02 Pressure Mediated Selective Delivery of Therapeutic Substances KR National Stage 10-2000-7013046 Abandoned
NHLBI E-196-1998-2-CA-05 Method for Pressure Mediated Selective Delivery of Therapeutic Substances and Cannula CA National Stage 2333039 Abandoned
NCI E-253-1993-0-US-08 Self-Assembling Recombinant Papillomavirus Capsid Proteins US CON 09/316,487 Abandoned
NICHD E-192-1999-0-US-01 System for Analyzing Diffusion Tensor Magnetic Resonance Images US 60/135,427 Abandoned
CC E-013-1999-0-US-01 Magnetic Resonance Tracking of Magnetically Labeled Cells US 60/135,428 Abandoned
NCI E-143-1998-0-EP-03 NOVEL POST-TRANSCRIPTIONAL REGULATORY ELEMENTS AND USES THEREOF EP National Stage 99924362.9 Abandoned
NCI E-143-1998-0-DE-06 NOVEL POST-TRANSCRIPTIONAL REGULATORY ELEMENTS AND USES THEREOF DE EP 99924362.9 Abandoned
NCI E-143-1998-0-FR-07 NOVEL POST-TRANSCRIPTIONAL REGULATORY ELEMENTS AND USES THEREOF FR EP 99924362.9 Abandoned
NCI E-143-1998-0-GB-08 NOVEL POST-TRANSCRIPTIONAL REGULATORY ELEMENTS AND USES THEREOF GB EP 99924362.9 Abandoned
NCI E-143-1998-0-PCT-02 NOVEL POST-TRANSCRIPTIONAL REGULATORY ELEMENTS AND USES THEREOF PCT PCT PCT/US1999/011082 Expired
NICHD E-027-1999-0-US-01 Materials and Methods for Enzymatic N-Acetylation of Arylalkylamines US 60/134,757 Abandoned
NIAID E-055-1999-0-US-01 Identification of Candidate Ligands Which Modulate Antigen Presenting Cells US ORD 09/313,487 6680176 Expired PDF
NHLBI E-204-1998-0-PCT-02 Methods and Compositions for HDL Holoparticle Uptake Receptor PCT PCT PCT/US1999/010619 Expired
NIMH E-088-1998-0-US-01 Strains of Bacteriophage Useful for Rescuing Patients Infected With Vancomycin-Resistant Enterococcus Faecium US 60/134,055 Abandoned
NCI E-036-1999-0-US-01 Thiazepine Inhibitors of HIV-1 Integrase US 60/133,726 Abandoned
NCI E-193-1995-0-US-04 METHODS FOR DETERMINING THE PROGNOSIS OF BREAST CANCER USING ANTIBODIES SPECIFIC FOR THYMIDYLATE SYNTHASE US DIV 09/310,459 Abandoned